Below a support letter by Rafael Cantera, professor of zoology at the University of Stockholm in Sweden, addressed to the leadership of the University Clinic Würzburg. This is because two professors of this German university, Thorsten Walles and Heike Mertsching (now Walles) chose to respond to my inquiries about their earlier trachea transplants made from pig intestine (see my detailed report here) with lawyers’ financial blackmail and right after, with court actions, which had me sentenced guilty with a threat of a prison term of 6 months, without my prior knowledge (see case description here). Such are the peculiarities of German law: internet bloggers are basically legally defined here by default as criminals, and professors as infallible and divine beings (in fact, even Walleses’ former boss and collaborator Paolo Macchiarini is still a protected adjunct professor at their former common place of work, the Medical University Hannover). I received lots of support from my readers, and was also invited to give an interview with the French magazine Mediapart (German version here). Now, I am deeply grateful to Prof. Cantera for his support, and hope other international and maybe even German academics join in and sign below. Continue reading “Open Letter in support of my investigation of trachea transplants in Germany, by Rafael Cantera”
The scandal-shaken Swedish Karolinska Institutet (KI) invited nine of their research group leaders and professors to explain themselves about data integrity concerns raised in regard to their publications. They have time until November 24th 2016 to address of the suspicions of image duplications which were posted on PubPeer by anonymous watchdogs and subsequently reported to Karolinska by a whistleblower. This was the email the 9 scientists received on November 10th from Lisen Samuelsson of KI’s legal department:
“Karolinska Institutet (KI) has been notified about inaccuracies in one or more scientific articles according to comments on the website PubPeer. You are named as the main author of the article (s) in question.
KI therefore requests that you provide a statement regarding whether the alleged inaccuracies are correct or not. If there are inaccuracies in the article (s), KI requests that you specify whether they have been corrected, or if they will be corrected, and if so, how. Please submit your statement to KI at firstname.lastname@example.org regarding this matter by November 24, 2016”.
The email was complemented by a list of these scientists’ respective PubPeer-flagged publications. Most of these 9 addressees are very senior KI researchers, like Ulla Stenius and Boris Zhivotovsky. Here is the list, with some background information:
If these days you should bump into the miracle surgeon Paolo Macchiarini, do not just greet him with some offhand “Ciao Paolo”. But also “Hello, Doctor Macchiarini” would not be respectful enough. As a saying goes among German clinicians: you must take your time, namely by addressing the great man in full as “Professor Doctor Macchiarini”. As we know, after investigations into the deaths and mutilation of a large number of his patients, the former star of regenerative medicine was sacked from his professorship at the Swedish Karolinska Institutet (KI), so that title is now definitely gone. Macchiarini’s other professorships which he used to convincingly carry in his CV, namely those from the University of Paris in France and University of Florence in Italy, proved to be fictional (see also KI report here). However, his adjunct professorship from the Medical University of Hannover (Medizinische Hochschule Hannover, MHH) in Germany is very much real. Here for a change it is not Macchiarini who is cheating, but the German university which allows him to carry that academic title against the state’s law on adjunct professorship, which binds it to ongoing teaching duties. Fortunately, the federal state of Lower Saxony (which owns this Hannover university) doesn’t seem to mind either. In fact, their officer for data protection told me it was none of my business asking whether Professor Macchiarini had been giving any lectures at MHH in the last years. Continue reading “Professor Macchiarini, because Medical University of Hannover wants it so”
The British research funder Wellcome Trust (now just Wellcome) is about to launch its own journal, where the funding recipients and their collaborators are invited to published their research free of charge (since Wellcome will be covering those costs). Wellcome Open Research will be open access (OA) and offer fully transparent post-publication peer review, i.e. all reviewer reports, manuscript versions as well as reviewer identities will be posted alongside the final articles. Manuscripts which received peer review approval will become proper research papers and feature accordingly on PubMed and other databases. Wellcome specifically invites scientists to publish negative and null results as well as databases. Importantly, the funder also promotes data sharing through “inclusion of supporting data”. The platform on which Wellcome Open Research will operate is that of F1000Research, a post-publication peer review journal which prides itself of its open science approach.
This sounds like excellent news for science, which is plagued by irreproducibility and misconduct crises, and many welcomed the Wellcome initiative, hoping that other national funding agencies in Europe, North America and elsewhere might follow. It is indeed the first serious attempt by a major western funder to move away from publisher-dependence towards a “samizdat”, a self-publishing service run exclusively for own researchers and their partners. However, a similar model of university press proved unsuccessful before and never became accepted by the scientific community. Therefore, some are sceptical that this Wellcome publishing enterprise may ever take off. Continue reading “Wellcoming the samizdat publishing revolution”
Times Higher Education recently reported about an online survey on research integrity of British scientists. The study was performed and evaluated by Joanna Williams and David Roberts, two scientists at the University of Kent (their full report here). Interestingly, they not only assessed scientists’ own self-reported research misconduct (this being a topic where scientists tend to be less than perfectly honest), but also the so-called “unmatched count”, which “allows respondents to indicate malpractice without specifically implicating themselves”. The sad, but hardly surprising results: one fifth of the respondents acknowledged having fabricated their research data, one out of seven admitted committing plagiarism, and more than a third “reported having published extracts from the same piece in more than one location”.
Self-plagiarism is a convenient tool to boost one’s publication record without doing any proper additional research. This is why many academics see extensive copy-pasting of one’s previously published text as a form of misconduct. Of note, this behaviour has nothing to do with occasional repetition of standard formulations or methods descriptions. However, when I reported in April 2016 about certain excessive cases of self-plagiarism, some of my readers strongly disagreed these were anywhere near research misconduct. They showed a more relaxed attitude to self-plagiarism, especially where literature reviews were concerned. Many even reject the term, and prefer to speak of ‘text re-use’, for the purpose of spreading own knowledge and ideas to reach wider masses. From this perspective, which many journal editors seem to share, exact double-publishing of the same review or opinion paper is still frowned upon, but it is enough to introduce some additional paragraphs or a slightest modification of focus to avoid a retraction. Continue reading “Self-Plagiarism: helps careers, hurts noone?”
I received a lawyer’s letter, where I am instructed to delete my report about the Berlin head ophthalmologist Antonia Joussen and to pay her legal costs of over €2000, with more damage claims to come. It was the June 2nd report on my site “Research data integrity: words and deeds of Berlin’s head ophthalmologist which provoked this reaction.
In brief, on behalf of Joussen the lawyer Johannes Eisenberg (who specialises in criminal law) denies band duplications, but acknowledges the criticised instances of gel splicing, while insisting this was an acceptable practice in academic publishing. He repeatedly refers to investigations by Joussen’s current employer the Berlin University Hospital Charité, who apparently exonerated Joussen just days (literally) after the concerns about her publications appeared on PubPeer in February 2015. On March 31st 2015 same Charité informed me that they decided not to declare their stand regarding Joussen’s criticised publications (evidence below). The Charité spokesperson instructed me to contact her previous employers, the universities of Cologne and Düsseldorf, who then refused sharing any information with me (in fact, the University of Düsseldorf research integrity ombudsman Ulrich Noack twice refused to reply to my emails). Now, Joussen’s lawyer abstains from naming which office or which “responsible employee” of the Charité had been performing these ultra-rapid investigations. Neither was any evidence or details of their image integrity analysis even mentioned. Continue reading “Berlin head ophthalmologist Joussen deploys lawyer to silence my reporting, demands from me €80,000 damages”
Susana González is a Spanish regenerative medicine scientist who promised to search for cures of heart ageing with the help of €1.9 Million from the EU public funder ERC, before in spring 2016 she lost it together with her group leader position at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid. Despite a misconduct investigation which led to Gonzalez sacking, ERC chose not to terminate her funding (unlike EMBO did with that of her similarly misconduct-tainted Iberian colleague Sonia Melo). ERC suspended this hefty sum, instead of re-using it for the funding of more honest applicants, while an ERC’s standing committees on ethics and integrity are investigating Gonzalez for possible research misconduct (see my report here).
Now it seems ERC might be able to give the freshly employed group leader Gonzalez her suspended funding back, that is, if they decide to do so. As I was informed by an insider source, Gonzalez is now employed from June 1st 2016 as group leader at the Centro de Biología Molecular Severo Ochoa (CBMSO) in Madrid. This zombie scientist did not even have to move house to find another tenured job in research. Here is one example of suspicious data irregularities in Gonzalez papers (listed on PubPeer): a western blot duplication across two publications from her lab (Herrero-Merchan et al 2012 and Arranz et al 2012): Continue reading “New tenured job for zombie scientist Susana Gonzalez”